A detailed history of Shell Asset Management CO transactions in Johnson & Johnson stock. As of the latest transaction made, Shell Asset Management CO holds 10,095 shares of JNJ stock, worth $1.47 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
10,095
Previous 10,055 0.4%
Holding current value
$1.47 Million
Previous $1.47 Million 11.29%
% of portfolio
0.07%
Previous 0.07%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$145.48 - $167.38 $5,819 - $6,695
40 Added 0.4%
10,095 $1.64 Million
Q1 2024

Jul 31, 2024

SELL
$155.22 - $162.74 $1.19 Million - $1.25 Million
-7,673 Reduced 43.28%
10,055 $1.47 Million
Q1 2024

May 14, 2024

BUY
$155.22 - $162.74 $242,453 - $254,199
1,562 Added 9.66%
17,728 $2.8 Million
Q4 2023

Feb 14, 2024

SELL
$145.6 - $158.88 $1.3 Million - $1.42 Million
-8,928 Reduced 35.58%
16,166 $2.53 Million
Q3 2023

Nov 08, 2023

SELL
$155.75 - $174.48 $352,306 - $394,673
-2,262 Reduced 8.27%
25,094 $3.91 Million
Q2 2023

Jul 28, 2023

SELL
$154.35 - $166.11 $393,901 - $423,912
-2,552 Reduced 8.53%
27,356 $4.53 Million
Q1 2023

May 15, 2023

SELL
$151.05 - $180.26 $7.02 Million - $8.38 Million
-46,489 Reduced 60.85%
29,908 $4.64 Million
Q4 2022

Feb 07, 2023

SELL
$160.2 - $179.79 $5.77 Million - $6.48 Million
-36,040 Reduced 32.05%
76,397 $13.5 Million
Q3 2022

Nov 14, 2022

SELL
$161.33 - $179.52 $1.46 Million - $1.62 Million
-9,035 Reduced 7.44%
112,437 $18.4 Million
Q2 2022

Aug 09, 2022

SELL
$168.19 - $186.01 $1.68 Million - $1.86 Million
-9,991 Reduced 7.6%
121,472 $21.6 Million
Q1 2022

May 04, 2022

BUY
$158.14 - $179.59 $5.57 Million - $6.33 Million
35,220 Added 36.59%
131,463 $23.3 Million
Q4 2021

Feb 09, 2022

SELL
$155.93 - $173.01 $8.82 Million - $9.79 Million
-56,590 Reduced 37.03%
96,243 $16.5 Million
Q3 2021

Nov 04, 2021

SELL
$161.5 - $179.47 $8.55 Million - $9.5 Million
-52,961 Reduced 25.73%
152,833 $24.7 Million
Q2 2021

Aug 12, 2021

SELL
$159.48 - $171.07 $19 Million - $20.4 Million
-119,083 Reduced 36.65%
205,794 $33.9 Million
Q1 2021

May 10, 2021

BUY
$153.07 - $170.48 $2.49 Million - $2.77 Million
16,273 Added 5.27%
324,877 $53.4 Million
Q4 2020

Feb 16, 2021

BUY
$137.11 - $157.38 $1.23 Million - $1.41 Million
8,978 Added 3.0%
308,604 $48.6 Million
Q3 2020

Nov 13, 2020

SELL
$140.38 - $153.83 $485,855 - $532,405
-3,461 Reduced 1.14%
299,626 $44.6 Million
Q2 2020

Aug 10, 2020

SELL
$128.81 - $155.51 $11.2 Million - $13.5 Million
-86,600 Reduced 22.22%
303,087 $42.6 Million
Q1 2020

May 11, 2020

SELL
$111.14 - $153.99 $790,427 - $1.1 Million
-7,112 Reduced 1.79%
389,687 $51.1 Million
Q4 2019

Feb 13, 2020

SELL
$127.5 - $146.44 $1.76 Million - $2.03 Million
-13,838 Reduced 3.37%
396,799 $57.9 Million
Q3 2019

Nov 12, 2019

SELL
$126.95 - $142.14 $2.87 Million - $3.21 Million
-22,614 Reduced 5.22%
410,637 $53.1 Million
Q2 2019

Aug 12, 2019

SELL
$131.15 - $144.24 $2.01 Million - $2.21 Million
-15,355 Reduced 3.42%
433,251 $60.3 Million
Q1 2019

May 09, 2019

SELL
$125.72 - $139.79 $1.09 Million - $1.22 Million
-8,706 Reduced 1.9%
448,606 $62.7 Million
Q4 2018

Feb 13, 2019

SELL
$122.84 - $147.84 $2.09 Million - $2.52 Million
-17,043 Reduced 3.59%
457,312 $59 Million
Q3 2018

Nov 13, 2018

BUY
$121.58 - $142.88 $2.33 Million - $2.74 Million
19,203 Added 4.22%
474,355 $65.5 Million
Q2 2018

Aug 10, 2018

SELL
$119.4 - $131.76 $4.33 Million - $4.78 Million
-36,290 Reduced 7.38%
455,152 $55.2 Million
Q1 2018

May 14, 2018

BUY
$125.1 - $148.14 $1.25 Million - $1.49 Million
10,030 Added 2.08%
491,442 $63 Million
Q4 2017

Feb 09, 2018

BUY
$131.22 - $143.62 $6.3 Million - $6.9 Million
48,015 Added 11.08%
481,412 $67.3 Million
Q3 2017

Oct 20, 2017

SELL
$129.47 - $135.38 $44.5 Million - $46.5 Million
-343,407 Reduced 44.21%
433,397 $56.3 Million
Q3 2017

Oct 18, 2017

BUY
$129.47 - $135.38 $101 Million - $105 Million
776,804
776,804 $82.8 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $381B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Shell Asset Management CO Portfolio

Follow Shell Asset Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shell Asset Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Shell Asset Management CO with notifications on news.